Complex, chronic wounds are increasingly recognized as life-altering conditions with mortality rates rivaling or surpassing certain cancers. A new publication from JWC entitled “Application of a ...

MediWound Ltd. (NASDAQ: MDWD) Q3 2025 Earnings Call Transcript November 20, 2025 MediWound Ltd. beats earnings expectations.

Mediwound ( ($MDWD) ) has released its Q3 earnings. Here is a breakdown of the information Mediwound presented to its investors. MediWound Ltd., a ...

Observed annually on the third Thursday of November each year, Worldwide Pressure Injury Prevention Day serves as a global ...

The wound healing devices market is largely propelled by the growing incidence of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure sores, along with a rise in surgical ...

Powys Teaching Health Board has confirmed it has made a series of changes following the death of Edward Funnell, from Llandrindod Wells ...

The latest announcement is out from Mediwound ( (MDWD) ).

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; ...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx- in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid- Facility; Full Operational Capacity Expected by Year-End 2025 ...

PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik ...

IRVINE, CA / ACCESS Newswire / November 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...